Cargando…
Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174327/ https://www.ncbi.nlm.nih.gov/pubmed/32317644 http://dx.doi.org/10.1038/s41467-020-16007-z |
| _version_ | 1783524614720192512 |
|---|---|
| author | Tamura, Ryota Fujioka, Masato Morimoto, Yukina Ohara, Kentaro Kosugi, Kenzo Oishi, Yumiko Sato, Mizuto Ueda, Ryo Fujiwara, Hirokazu Hikichi, Tetsuro Noji, Shinobu Oishi, Naoki Ogawa, Kaoru Kawakami, Yutaka Ohira, Takayuki Yoshida, Kazunari Toda, Masahiro |
| author_facet | Tamura, Ryota Fujioka, Masato Morimoto, Yukina Ohara, Kentaro Kosugi, Kenzo Oishi, Yumiko Sato, Mizuto Ueda, Ryo Fujiwara, Hirokazu Hikichi, Tetsuro Noji, Shinobu Oishi, Naoki Ogawa, Kaoru Kawakami, Yutaka Ohira, Takayuki Yoshida, Kazunari Toda, Masahiro |
| author_sort | Tamura, Ryota |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7174327 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71743272020-04-28 Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 Tamura, Ryota Fujioka, Masato Morimoto, Yukina Ohara, Kentaro Kosugi, Kenzo Oishi, Yumiko Sato, Mizuto Ueda, Ryo Fujiwara, Hirokazu Hikichi, Tetsuro Noji, Shinobu Oishi, Naoki Ogawa, Kaoru Kawakami, Yutaka Ohira, Takayuki Yoshida, Kazunari Toda, Masahiro Nat Commun Author Correction Nature Publishing Group UK 2020-04-21 /pmc/articles/PMC7174327/ /pubmed/32317644 http://dx.doi.org/10.1038/s41467-020-16007-z Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Author Correction Tamura, Ryota Fujioka, Masato Morimoto, Yukina Ohara, Kentaro Kosugi, Kenzo Oishi, Yumiko Sato, Mizuto Ueda, Ryo Fujiwara, Hirokazu Hikichi, Tetsuro Noji, Shinobu Oishi, Naoki Ogawa, Kaoru Kawakami, Yutaka Ohira, Takayuki Yoshida, Kazunari Toda, Masahiro Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title | Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_full | Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_fullStr | Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_full_unstemmed | Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_short | Author Correction: A VEGF receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| title_sort | author correction: a vegf receptor vaccine demonstrates preliminary efficacy in neurofibromatosis type 2 |
| topic | Author Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174327/ https://www.ncbi.nlm.nih.gov/pubmed/32317644 http://dx.doi.org/10.1038/s41467-020-16007-z |
| work_keys_str_mv | AT tamuraryota authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT fujiokamasato authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT morimotoyukina authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT oharakentaro authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kosugikenzo authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT oishiyumiko authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT satomizuto authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT uedaryo authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT fujiwarahirokazu authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT hikichitetsuro authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT nojishinobu authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT oishinaoki authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT ogawakaoru authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT kawakamiyutaka authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT ohiratakayuki authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT yoshidakazunari authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 AT todamasahiro authorcorrectionavegfreceptorvaccinedemonstratespreliminaryefficacyinneurofibromatosistype2 |